# Eledon Pharmaceuticals, Inc.: Form 8-K, filed Nov 8, 2017

- Company: [Eledon Pharmaceuticals, Inc.](/companies/eldn.md) (CIK 1404281)
- Form: 8-K
- Filed: 2017-11-08
- Accepted by EDGAR: Nov 8, 2017, 16:50 ET
- Period: 2017-11-08
- Accession: 0001564590-17-022812
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1404281/000156459017022812/nvus-8k_20171108.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1404281/000156459017022812/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1404281/000156459017022812/nvus-8k_20171108.htm

Filed Nov 8, 2017.
Source: SEC EDGAR, the filing index for accession 0001564590-17-022812. Last ingested by Listed: Nov 13, 2026, 16:16 ET. No prices; not investment advice.
